In vivo experiments, using both subcutaneous and orthotopic mouse models of HCC, revealed that rVP1 suppressed tumor growth, inhibited intra-hepatic metastasis, and showed survival benefit. The gene discussed is CLDN3; the disease is hepatocellular carcinoma.